Indivi

Indivi is a leading Medtech for the development of digital measurements > biomarkers in neuroscience, headquartered in Basel, Switzerland. Indivi is committed to developing and validating transformative digital endpoints to accelerate and de-risk drug development in neurodegenerative diseases, with a focus on multiple sclerosis, Parkinsons and Alzheimers diseases. Through its exclusive partnership with Basel University Faculty of Medicine and the Research Center for Clinical Neuroimmunology and Neuroscience in Basel (RC2NB), Indivi is dedicated to unlocking the potential of digital endpoints and precision medicine in drug development by creating a fertile symbiotic intersection of knowledge in Data Science, Clinical Science and...

E-health,clinical trials,neurology,neurodegeneration,digital health technology,biomarkers,measurement,precision medicine,personalized medicine,machine learning,healthcare,mobile solutions,remote patient monitoring,connected care,software as medical device,medical device,and digital endpoints

Indivi operates in the Medical equipment manufacturing industry.

Indivi's revenue is 11m - 100m

Indivi has 51 - 200 employees.